Corvus Pharmaceuticals, Inc.
Clinical trials sponsored by Corvus Pharmaceuticals, Inc., explained in plain language.
-
New hope for tough lymphoma: targeted drug soquelitinib faces standard care in phase 3 trial
Disease control Recruiting nowThis study tests a new drug called soquelitinib against standard single-agent treatments in 150 adults with certain types of T-cell lymphoma that have come back or not responded to prior therapy. The goal is to see if soquelitinib can delay cancer progression better than current …
Phase: PHASE3 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 08:30 UTC
-
New eczema pill shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis study tests a new daily pill, soquelitinib, in 200 adults with moderate to severe atopic dermatitis (eczema). Participants take the drug or a placebo for 12 weeks. Doctors track skin improvements and side effects to see if the drug is safe and works better than a dummy pill.
Phase: PHASE2 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC